Telomere shortening in elderly individuals with mild cognitive impairment may be attenuated with ω-3 fatty acid supplementation: A randomized controlled pilot study

Nutrition

Volumn 30, Issue 4, 2014, Pages 489-491

  O'Callaghan, Nathan ^a   Parletta, Natalie ^b   Milte, Catherine M ^b   Benassi Evans, Bianca ^a   Fenech, Michael ^a   Howe, Peter R C ^b,c  

^a CSIRO   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

DHA; Elderly; EPA; Mild cognitive impairment; Telomere length; 3 fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LINOLEIC ACID;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; HUMAN; MILD COGNITIVE IMPAIRMENT; NUTRIENT CONCENTRATION; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; TREATMENT DURATION; TREATMENT RESPONSE;

DHA; ELDERLY; EPA; MILD COGNITIVE IMPAIRMENT; TELOMERE LENGTH; Ω-3 FATTY ACIDS;

AGED; AGING; ALPHA-LINOLENIC ACID; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ERYTHROCYTES; HUMANS; MILD COGNITIVE IMPAIRMENT; PILOT PROJECTS; TELOMERE SHORTENING;

EID: 84950170722     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.09.013     Document Type: Article

References (11)

1. Blackburn E.H. Telomeres. Trends Biochem Sci 1991, 16:378-381.
2. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
3. Martin-Ruiz C., Dickinson H.O., Keys B., Rowan E., Kenny R.A., Von Zglinicki T. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol 2006, 60:174-180.
4. Thomas P., OC N.J., Fenech M. Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease. Mech Ageing Dev 2008, 129:183-190.
5. Zerky D., Hermann F.R., Irminger-Finder I., Ortolan L., Genet C., Vitale A.M., et al. Telomere length is not predictive of dementia or MCI conversion in the oldest old. Neurobiol Aging 2010, 31:719-720.
6. Devore E.E., Prescott J., De Vivo I., Grodstein F. Relative telomere length and cognitive decline in the Nurses' Health Study. Neurosci Lett 2011, 492:15-18.
7. Sinn N., Milte C., Howe P.R. Oiling the brain: A review of randomised controlled trials of omega-3 fatty acids in psychopathology across the lifespan. Nutrients 2010, 2:128-170.
8. Farzaneh-Far R., Lin J., Epel E.S., Harris W.S., Blackburn E.H., Whooley M.A. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA 2011, 303:250-257.
9. Kiecolt-Glaser J.K., Epel E.S., Belury M.A., Andridge R., Lin J., Glaser R., et al. Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial. Brain Behav Immun 2013, 28:16-24.
10. Sinn N., Milte C.M., Street S.J., Buckley J.D., Coates A.M., Petkov J., et al. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr 2012, 20:1-12.
11. O'Callaghan N., Dhillon V., Thomas P., Fenech M. A quantitative real-time PCR method for absolute telomere length. Biotechniques 2008, 44:807-809.